-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 9, CSPC announced that its wholly-owned subsidiary CSPC (Shanghai) Co.
According to the agreement, CSPC Shanghai will obtain the exclusive rights of BPI-7711 capsules to carry out commercialization activities of BPI-7711 capsules in the People’s Republic of China (including Hong Kong Special Administrative Region and Macau Special Administrative Region, but excluding Taiwan) and own BPI -1178 Capsules (CDK4/6 inhibitor) commercialization authorization priority negotiation right.